GEHCGE HealthCare

Health care · Medical Imaging · Nasdaq

GEHC and 9 peers, year by year

The 9 Health care companies closest to GEHC in revenue over the last twelve months. Every number is from the 10-K and links to it in SEC's Inline XBRL viewer.

5 years 10 years Download CSV

Choose the peers

Each company's latest fiscal year
Company	Year	Revenue	Sales growth	Gross margin	Operating margin	Net margin	FCF margin	Return on equity	Debt / equity
GEHC GE HealthCare	FY2025	$20.6B	+4.8%	40.0%	13.4%	10.1%	7.3%	20.1%	1.01
BSX Boston Scientific	FY2025	$20.1B	+19.9%	69.0%	18.0%	14.4%	18.2%	12.0%	0.47
BDX Becton Dickinson	FY2025	$21.8B	+8.2%	-	11.8%	7.7%	12.2%	6.6%	0.76
UHS Universal Health Services	FY2025	$17.4B	+9.7%	-	11.5%	8.6%	4.9%	20.5%	0.66
DHR Danaher Corporation	FY2025	$24.6B	+2.9%	59.1%	19.1%	14.7%	21.4%	6.9%	0.35
IQV IQVIA	FY2025	$16.3B	+5.9%	-	13.4%	8.3%	12.6%	20.9%	2.42
SYK Stryker Corporation	FY2025	$25.1B	+11.2%	64.0%	19.5%	12.9%	17.1%	14.5%	0.66
REGN Regeneron Pharmaceuticals	FY2025	$14.3B	+1.0%	-	24.9%	31.4%	28.4%	14.4%	0.06
VTRS Viatris	FY2025	$14.3B	−3.0%	35.1%	−18.6%	−24.6%	13.5%	−23.9%	0.98
LH Labcorp	FY2025	$14.0B	+7.2%	28.8%	9.9%	6.3%	8.6%	10.2%	0.65

Revenuepeer median $17.4B

Sales growthpeer median +7.2%

Gross marginpeer median 59.1%

BSX 69.0%
SYK 64.0%
DHR 59.1%
GEHC 40.0%
VTRS 35.1%
LH 28.8%
BDX -
UHS -
IQV -
REGN -

Operating marginpeer median 13.4%

Net marginpeer median 8.6%

FCF marginpeer median 13.5%

Return on equitypeer median 12.0%

Debt / equitypeer median 0.66

IQV 2.42
GEHC 1.01
VTRS 0.98
BDX 0.76
SYK 0.66
UHS 0.66
LH 0.65
BSX 0.47
DHR 0.35
REGN 0.06

RevenueSales growthGross marginOperating marginNet marginFree cash flowFCF marginReturn on equityDebt / equityEPS (diluted)

Revenue, FY2021 to FY2025

Revenue as reported in the 10-K.

Company	FY2021	FY2022	FY2023	FY2024	FY2025
GEHC Dec	$17.6B	$18.3B	$19.6B	$19.7B	$20.6B
BSX Dec	$11.9B	$12.7B	$14.2B	$16.7B	$20.1B
BDX Sep	$19.1B	$18.9B	$19.4B	$20.2B	$21.8B
UHS Dec	$12.6B	$13.4B	$14.3B	$15.8B	$17.4B
DHR Dec	$24.8B	$26.6B	$23.9B	$23.9B	$24.6B
IQV Dec	$13.9B	$14.4B	$15.0B	$15.4B	$16.3B
SYK Dec	$17.1B	$18.4B	$20.5B	$22.6B	$25.1B
REGN Dec	$16.1B	$12.2B	$13.1B	$14.2B	$14.3B
VTRS Dec	$17.9B	$16.3B	$15.4B	$14.7B	$14.3B
LH Dec	$11.9B	-	$12.2B	$13.0B	$14.0B
Peer median	$16.1B	$15.3B	$15.0B	$15.8B	$17.4B

Sales growth, FY2021 to FY2025

Revenue against the fiscal year before.

Company	FY2021	FY2022	FY2023	FY2024	FY2025
GEHC Dec	-	+4.3%	+6.6%	+0.6%	+4.8%
BSX Dec	+19.9%	+6.7%	+12.3%	+17.6%	+19.9%
BDX Sep	+19.0%	−1.4%	+2.7%	+4.2%	+8.2%
UHS Dec	+9.4%	+6.0%	+6.6%	+10.8%	+9.7%
DHR Dec	+32.2%	+7.4%	−10.3%	−0.1%	+2.9%
IQV Dec	+22.1%	+3.9%	+4.0%	+2.8%	+5.9%
SYK Dec	+19.2%	+7.8%	+11.1%	+10.2%	+11.2%
REGN Dec	+89.1%	−24.3%	+7.8%	+8.3%	+1.0%
VTRS Dec	+50.7%	−9.0%	−5.1%	−4.5%	−3.0%
LH Dec	−9.7%	-	+2.5%	+7.0%	+7.2%
Peer median	+19.9%	+4.9%	+4.0%	+7.0%	+7.2%

Gross margin, FY2021 to FY2025

Gross profit / revenue.

Company	FY2021	FY2022	FY2023	FY2024	FY2025
GEHC Dec	40.8%	39.1%	40.5%	41.7%	40.0%
BSX Dec	68.8%	68.8%	69.5%	68.6%	69.0%
BDX Sep	-	-	-	-	-
UHS Dec	-	-	-	-	-
DHR Dec	61.4%	60.8%	58.7%	59.5%	59.1%
IQV Dec	-	-	-	-	-
SYK Dec	64.1%	62.8%	63.7%	63.9%	64.0%
REGN Dec	-	-	-	-	-
VTRS Dec	31.2%	40.0%	41.7%	38.2%	35.1%
LH Dec	31.3%	-	27.7%	27.9%	28.8%
Peer median	61.4%	61.8%	58.7%	59.5%	59.1%

Operating margin, FY2021 to FY2025

Operating income / revenue.

Company	FY2021	FY2022	FY2023	FY2024	FY2025
GEHC Dec	15.9%	13.8%	12.5%	13.3%	13.4%
BSX Dec	10.1%	13.0%	16.5%	15.5%	18.0%
BDX Sep	11.8%	12.1%	10.9%	11.9%	11.8%
UHS Dec	10.8%	7.5%	8.2%	10.6%	11.5%
DHR Dec	25.7%	28.3%	21.8%	20.4%	19.1%
IQV Dec	10.0%	12.5%	13.2%	14.3%	13.4%
SYK Dec	15.1%	15.4%	19.0%	16.3%	19.5%
REGN Dec	55.7%	38.9%	30.9%	28.1%	24.9%
VTRS Dec	−0.2%	9.9%	5.0%	0.1%	−18.6%
LH Dec	12.1%	-	6.0%	8.4%	9.9%
Peer median	11.8%	12.7%	13.2%	14.3%	13.4%

Net margin, FY2021 to FY2025

Net income / revenue.

Company	FY2021	FY2022	FY2023	FY2024	FY2025
GEHC Dec	12.8%	10.4%	8.0%	10.1%	10.1%
BSX Dec	8.3%	5.1%	11.0%	11.1%	14.4%
BDX Sep	10.9%	9.4%	7.7%	8.4%	7.7%
UHS Dec	7.8%	5.0%	5.0%	7.2%	8.6%
DHR Dec	25.9%	27.1%	19.9%	16.3%	14.7%
IQV Dec	7.0%	7.6%	9.1%	8.9%	8.3%
SYK Dec	11.7%	12.8%	15.4%	13.2%	12.9%
REGN Dec	50.2%	35.6%	30.1%	31.1%	31.4%
VTRS Dec	−7.1%	12.8%	0.4%	−4.3%	−24.6%
LH Dec	10.8%	-	3.4%	5.7%	6.3%
Peer median	10.8%	11.1%	9.1%	8.9%	8.6%

Free cash flow, FY2021 to FY2025

Cash from operations minus capital spending.

Company	FY2021	FY2022	FY2023	FY2024	FY2025
GEHC Dec	$1.4B	$1.8B	$1.7B	$1.6B	$1.5B
BSX Dec	$1.3B	$938.0M	$1.8B	$2.6B	$3.7B
BDX Sep	$3.5B	$1.5B	$2.1B	$3.1B	$2.7B
UHS Dec	$28.0M	$262.0M	$524.7M	$1.1B	$849.2M
DHR Dec	$7.1B	$7.4B	$5.8B	$5.3B	$5.3B
IQV Dec	$2.3B	$1.6B	$1.5B	$2.1B	$2.1B
SYK Dec	$2.7B	$2.0B	$3.1B	$3.5B	$4.3B
REGN Dec	$6.5B	$4.4B	$3.9B	$3.7B	$4.1B
VTRS Dec	$2.6B	$2.6B	$2.5B	$2.0B	$1.9B
LH Dec	$1.5B	-	$874.1M	$1.1B	$1.2B
Peer median	$2.6B	$1.8B	$2.1B	$2.6B	$2.7B

FCF margin, FY2021 to FY2025

Free cash flow / revenue.

Company	FY2021	FY2022	FY2023	FY2024	FY2025
GEHC Dec	7.7%	9.9%	8.8%	7.9%	7.3%
BSX Dec	11.1%	7.4%	12.6%	15.8%	18.2%
BDX Sep	18.0%	7.9%	10.9%	15.5%	12.2%
UHS Dec	0.2%	2.0%	3.7%	7.1%	4.9%
DHR Dec	28.7%	27.8%	24.2%	22.2%	21.4%
IQV Dec	16.6%	11.0%	10.0%	13.7%	12.6%
SYK Dec	16.0%	11.0%	15.3%	15.4%	17.1%
REGN Dec	40.6%	36.3%	29.5%	25.8%	28.4%
VTRS Dec	14.3%	15.9%	16.4%	13.4%	13.5%
LH Dec	12.9%	-	7.2%	8.4%	8.6%
Peer median	16.0%	11.0%	12.6%	15.4%	13.5%

Return on equity, FY2021 to FY2025

Net income / shareholders' equity at the year end.

Company	FY2021	FY2022	FY2023	FY2024	FY2025
GEHC Dec	13.5%	20.5%	22.0%	23.6%	20.1%
BSX Dec	5.9%	3.7%	8.1%	8.5%	12.0%
BDX Sep	8.8%	7.0%	5.8%	6.6%	6.6%
UHS Dec	16.3%	11.4%	11.7%	17.1%	20.5%
DHR Dec	14.2%	14.4%	8.9%	7.9%	6.9%
IQV Dec	16.0%	18.9%	22.2%	22.6%	20.9%
SYK Dec	13.4%	14.2%	17.0%	14.5%	14.5%
REGN Dec	43.0%	19.1%	15.2%	15.0%	14.4%
VTRS Dec	−6.2%	9.9%	0.3%	−3.4%	−23.9%
LH Dec	12.7%	-	5.3%	9.3%	10.2%
Peer median	13.4%	12.8%	8.9%	9.3%	12.0%

Debt / equity, FY2021 to FY2025

Total debt / shareholders' equity at the year end.

Company	FY2021	FY2022	FY2023	FY2024	FY2025
GEHC Dec	-	0.88	1.46	1.24	1.01
BSX Dec	0.55	0.51	0.47	0.49	0.47
BDX Sep	0.74	0.64	0.62	0.78	0.76
UHS Dec	0.69	0.81	0.80	0.68	0.66
DHR Dec	0.49	0.40	0.38	0.33	0.35
IQV Dec	2.01	2.21	2.24	2.30	2.42
SYK Dec	0.84	0.71	0.59	0.59	0.66
REGN Dec	0.11	0.09	0.08	0.07	0.06
VTRS Dec	1.13	0.91	0.89	0.75	0.98
LH Dec	0.53	-	0.64	0.79	0.65
Peer median	0.69	0.67	0.62	0.68	0.66

EPS (diluted), FY2021 to FY2025

Diluted earnings per share, on today's share count after splits.

Company	FY2021	FY2022	FY2023	FY2024	FY2025
GEHC Dec	$4.95	$4.22	$3.03	$4.34	$4.55
BSX Dec	$0.69	$0.45	$1.07	$1.25	$1.94
BDX Sep	$6.85	$5.88	$4.94	$5.86	$5.82
UHS Dec	$11.82	$9.14	$10.23	$16.82	$23.10
DHR Dec	$8.61	$9.66	$6.38	$5.29	$5.05
IQV Dec	$4.95	$5.72	$7.29	$7.49	$7.84
SYK Dec	$5.21	$6.17	$8.25	$7.76	$8.40
REGN Dec	$71.97	$38.22	$34.77	$38.34	$41.48
VTRS Dec	−$1.05	$1.71	$0.05	−$0.53	−$3.00
LH Dec	$13.97	-	$4.77	$8.84	$10.46
Peer median	$6.85	$6.03	$6.38	$7.49	$7.84

Fiscal years are lined up as each company's 10-K names them; the month next to a ticker is when its year ends. Hover a number for the XBRL line items and the filing; click it to open the filing on sec.gov. "n/m" means not meaningful: equity below zero, or a base so close to zero that the ratio says nothing. The peer median leaves out GEHC and needs at least three peers with the number. P/E, P/S and P/FCF at each year end appear here once the site has daily prices. What the same companies write about AI, tariffs and more →

Next Industry numbers →

Work on GEHC in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/GEHC/export.csv") into a cell.